Prokidney announces manufacturing efficiency initiatives and supply chain streamlining expected to reduce react™ manufacturing costs

Company anticipates that costs for react™ could decrease by up to 50% compared to the cost of manufacturing for its phase 2 clinical trial company anticipates that costs for react™ could decrease by up to 50% compared to the cost of manufacturing for its phase 2 clinical trial
PROK Ratings Summary
PROK Quant Ranking